Cargando…

Promotion effect of extracts from plastrum testudinis on alendronate against glucocorticoid-induced osteoporosis in rat spine

Alendronate (ALN) is a key therapeutic used to treat glucocorticoid-induced osteoporosis (GIOP), but may induce severe side effects. We showed earlier that plastrum testudinis extracts (PTE) prevented and treated GIOP in vivo. However, clinically, PTE is seldom used alone. Herein, we reveal the syne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Hui, Shen, Gengyang, Tang, Jingjing, Qiu, Ting, Zhang, Zhida, Zhao, Wenhua, Yu, Xiang, Huang, Jinjing, Liang, De, Yao, Zhensong, Yang, Zhidong, Jiang, Xiaobing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587701/ https://www.ncbi.nlm.nih.gov/pubmed/28878388 http://dx.doi.org/10.1038/s41598-017-10614-5

Ejemplares similares

Effect of Plastrum Testudinis Extracts on the Proliferation and Osteogenic Differentiation of rBMSCs by Regulating p38 MAPK-Related Genes
por: Shang, Qi, et al.
Publicado: (2019)

Plastrum testudinis Ameliorates Oxidative Stress in Nucleus Pulposus Cells via Downregulating the TNF-α Signaling Pathway
por: Zhang, Peng, et al.
Publicado: (2023)

Plastrum Testudinis Extract Mitigates Thiram Toxicity in Broilers via Regulating PI3K/AKT Signaling
por: Qamar, Hammad, et al.
Publicado: (2019)

Plastrum Testudinis Extracts Promote NSC Differentiation into Dopaminergic Neuron by Regulating the Interaction of TET1 and FoxA2
por: Zhong, Jun, et al.
Publicado: (2020)

A novel non-sequencing approach for rapid authentication of Testudinis Carapax et Plastrum and Trionycis Carapax by species-specific primers
por: Yang, Huan, et al.
Publicado: (2018)

Zuo-Gui-Wan Aqueous Extract Ameliorates Glucocorticoid-Induced Spinal Osteoporosis of Rats by Regulating let-7f and Autophagy
por: Shen, Gengyang, et al.
Publicado: (2022)

miR-330–5p in Small Extracellular Vesicles Derived From Plastrum testudinis-Preconditioned Bone Mesenchymal Stem Cells Attenuates Osteogenesis by Modulating Wnt/β-Catenin Signaling
por: Li, Xiaoyun, et al.
Publicado: (2021)

miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss
por: Shen, Gengyang, et al.
Publicado: (2020)

Research on the Mechanism of Kaempferol for Treating Senile Osteoporosis by Network Pharmacology and Molecular Docking
por: Tang, Fuyu, et al.
Publicado: (2022)

Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss
por: Shen, Gengyang, et al.
Publicado: (2020)

Alendronate prevents glucocorticoid-induced osteoporosis in patients with rheumatic diseases: A meta-analysis
por: Kan, Shun-Li, et al.
Publicado: (2016)

Jingui Shenqi Pills Regulate Bone-Fat Balance in Murine Ovariectomy-Induced Osteoporosis with Kidney Yang Deficiency
por: Shang, Qi, et al.
Publicado: (2020)

Alendronate Sodium in the Management of Osteoporosis
por: Prinsloo, P J J, et al.
Publicado: (2006)

Effects of alendronate for treatment of glucocorticoid-induced osteoporosis: A meta-analysis of randomized controlled trials
por: Wang, Ya-Kang, et al.
Publicado: (2018)

The effects of denosumab and alendronate on glucocorticoid-induced osteoporosis in patients with glomerular disease: A randomized, controlled trial
por: Iseri, Ken, et al.
Publicado: (2018)

Bioinformatics identification and experimental validation of m6A-related diagnostic biomarkers in the subtype classification of blood monocytes from postmenopausal osteoporosis patients
por: Zhang, Peng, et al.
Publicado: (2023)

An effect comparison of alendronate and teriparatide in patients with glucocorticoid-induced osteoporosis: A protocol for systematic review and meta-analysis
por: Liang, Na, et al.
Publicado: (2022)

Alendronate improves QOL of postmenopausal women with osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2010)

Meta-regression analysis of the efficacy of alendronate for prevention of glucocorticoid-induced fractures
por: Qiu, Mei, et al.
Publicado: (2020)

The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies
por: Chen, Ling-Xiao, et al.
Publicado: (2015)

The efficiency and safety of alendronate versus teriparatide for treatment glucocorticoid-induced osteoporosis: A meta-analysis and systematic review of randomized controlled trials
por: Liu, Zhi-Ming, et al.
Publicado: (2022)

Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2010)

A critical review of brand and generic alendronate for the treatment of osteoporosis
por: Brown, Jacques P, et al.
Publicado: (2013)

Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women
por: Um, Mi Jung, et al.
Publicado: (2017)

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
por: Kim, Yeesuk, et al.
Publicado: (2020)

Alendronate increases BMD at appendicular and axial skeletons in patients with established osteoporosis
por: Qin, Ling, et al.
Publicado: (2007)

Impact of Generic Alendronate Cost on the Cost-Effectiveness of Osteoporosis Screening and Treatment
por: Nayak, Smita, et al.
Publicado: (2012)

Treatment of Osteoporosis with Antiresoptive agent, Alendronate - warrants careful follow-up
por: Jain, Sumit Kumar, et al.
Publicado: (2011)

Role of Alendronate in Managing Osteoporosis in Celiac Disease – Illustrative Case Report
por: Widjaja, David, et al.
Publicado: (2011)

Effects of pentoxifylline and alendronate on fracture healing in ovariectomy-induced osteoporosis in rats
por: Vashghani Farahani, Mohammad-Mahdi, et al.
Publicado: (2019)

A prospective comparative study of intravenous alendronate and ibandronate for the treatment of osteoporosis
por: Horikawa, Akira, et al.
Publicado: (2019)

Enhanced osteogenic differentiation of alendronate-conjugated nanodiamonds for potential osteoporosis treatment
por: Ahn, Guk Young, et al.
Publicado: (2021)

Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States
por: Le, Quang A., et al.
Publicado: (2018)

Glucocorticoid-induced osteoporosis
por: Briot, Karine, et al.
Publicado: (2015)

Glucocorticoid-induced Osteoporosis
por: Cherian, Kripa Elizabeth, et al.
Publicado: (2017)

Efficacy of glucosamine alendronate alone & in combination with dihydroquercetin for treatment of osteoporosis in animal model
por: Muraleva, Natalya A., et al.
Publicado: (2012)

A comparative study between intravenous and oral alendronate administration for the treatment of osteoporosis
por: Horikawa, Akira, et al.
Publicado: (2015)

Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis
por: Leder, Benjamin Z, et al.
Publicado: (2019)

Knowledge and compliance towards alendronate therapy among postmenopausal women with osteoporosis in Palestine
por: Radwan, Asma, et al.
Publicado: (2022)

The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial
por: Piriyakhuntorn, Pokpong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ir22rham9vjttfapi1b6a8cddl